유전자 검사를 통해 진단한 선천성 신성 요붕증 1례
A Case of Congenital Nephrogenic Diabetes Insipidus Diagnosed by DNA Analysis
0
조회
0
다운로드
0
인용
0
참고문헌
초록
저자들은 불규칙한 발열은 주소로 내원한 5개월 된 어린 영아에서 유전자 검사를 통하여 선천성 신성 요붕증을 조기 확진하였으며 thiazide 치료에 반응을 보였기에 문헌고찰과 함께 보고하는 바이다.
Abstract
Nephrogenic diabetes insipidus(NDI) is characterized by an inability to concentrate urine despite normal or elevated plasma concentrations of the antidiuretic hormone; arginine vasopressin(AVP). Polyuria with hyposthenuria, and polydipsia are the cardinal clinical manifestations of the disease. Ninety percent of congenital nephrogenic diabetes insipidus patients are males with the X-linked recessive form of the disease; the mutation is in the AVP receptor 2 gene(AVPR2), which is located in chromosomal region Xq28. We report a case of NDI who suffered from unexplained fever and failure to thrive, which has been recognized since about 3 months after birth. His genomic DNA analysis identified a novel AVPR2 gene mutation as W200C.
참고문헌 (22)
- "Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus", 10, pp.1958~64 (1999)
- "Molecular cloning of the receptor for human antidiuretic hormone", 357, pp.333~5 (1992)
- "Structure and chromosomal localization of the human antidiuretic hormone receptor gene", 51, pp.1078~83 (1992)
- "An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression,affinity for ligand,and coupling to the Gs", adenyl cyclase system, 1994, pp.8, 886~94
- "Molecular and cellular defects in nephrogenic diabetes insipidus", 16, pp.1146~52 (2001)
- "In vitro mutagenesis and search for structure-function relationships among G-protein-coupled receptors", 283, pp.1~19 (1992)
- "Nephrogenic diabetes insipidus functional analysis of new AVPR2 mutations identified in Italin families", 11, pp.1033~43 (2000)
- "V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms", 12, pp.196~205 (1998)
- "Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families", 85, pp.1703~10 (2000)
- "Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congenital nephrogenic diabetes insipidus", 164, pp.31~9 (2000)
- "A case of congenital partial nephrogenic diabetes insipidus", 45, pp.902~5 (2002)
- "A molecular genetic study of X-linked nephrogenic diabetes insipidus", 35, pp.99~104 (1994)
- "Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus", 75, pp.431~7 (1997)
- "Vasopressin receptors in health and disease", 49, pp.1706~11 (1996)
- "Biochemical basis of partial nephrogenic diabetes insipidus phenotypes", 1, pp.1806~13 (1997)
- "Diabetes inspidus in pediatrics. In : Meikle AW, editor. Hormone replacement therapy. Totowa : Humana Press,", pp.3~38 (1999)
- "Antidiuretic hormone : Normal and disordered function. In : Klibanski A. editor. Endocrinol Metab Clin North Am. Philaelphia : WB Saunders Co", 30, pp.671~94 (2001)
- "A water deprivation test for the differential diagnosis of polyuria", 185, pp.699~703 (1963)
- "A water deprivation test for the diagnosis of diabetes insipidus in children", 114, pp.157~60 (1967)
- "Renal prostaglandin E2 in nephrogenic diabetes insipidus;Effects of inhibition of prostaglandin synthesis by indomethacin", 97, pp.476~8 (1980)
- "Tolmetin sodium in the management of nephrogenic diabetes insipidus", 101, pp.787~9 (1982)
- "Vasopressin receptor mutations and nephrogenic diabetes insipidus", 30, pp.465~74 (1999)
